PHAT R&D Expenses
Phathom Pharmaceuticals Inc · R&D Expenses
PHAT R&D Expenses
Latest reported$30.10Mperiod ending
PHAT TTM R&D Expenses ($20.00K → $30.10M)
TTM R&D Expenses
High-resolution chart · PNG
PHAT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 30,104,000 | |
| 31,367,000 | |
| 32,780,000 | |
| 33,870,000 | |
| 35,536,000 | |
| 33,836,000 | |
| 34,082,000 | |
| 38,892,000 | |
| 42,462,000 | |
| 47,850,000 | |
| 49,899,000 | |
| 52,452,000 | |
| 59,209,000 | |
| 65,260,000 | |
| 71,441,000 | |
| 69,048,000 | |
| 66,636,000 | |
| 69,418,000 | |
| 72,338,000 | |
| 100,439,000 | |
| 109,601,000 | |
| 102,863,000 | |
| 98,148,000 | |
| 69,198,000 | |
| 47,897,000 | |
| 114,707,000 | |
| 99,271,000 | |
| 86,581,000 | |
| 82,118,000 | |
| 449,000 | |
| 20,000 |